Cliff Asness's DNTH Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 4,118 shares of Dianthus Therapeutics, Inc. (DNTH) worth $345,582, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in DNTH, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Dianthus Therapeutics (DNTH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Dianthus Therapeutics (DNTH) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +4,118 | New Buy | 4,118 | $83.92 |
Cliff Asness's Dianthus Therapeutics Investment FAQs
Cliff Asness first purchased Dianthus Therapeutics, Inc. (DNTH) in Q1 2026, acquiring 4,118 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Dianthus Therapeutics, Inc. (DNTH) for 1 quarters since Q1 2026.
Cliff Asness's largest addition to Dianthus Therapeutics, Inc. (DNTH) was in Q1 2026, adding 4,118 shares worth $345,582.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 4,118 shares of Dianthus Therapeutics, Inc. (DNTH), valued at approximately $345,582.
As of the Q1 2026 filing, Dianthus Therapeutics, Inc. (DNTH) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Dianthus Therapeutics, Inc. (DNTH) was 4,118 shares, as reported at the end of Q1 2026.